The recombinant protein is synthesized in E. coli using standard prokaryotic expression systems. Critical steps include:
Cloning: Insertion of the CLI_0469 gene into a plasmid vector with a His tag.
Induction: IPTG-mediated expression optimization for yield.
Purification: Nickel-affinity chromatography (via His tag) followed by buffer exchange.
Commercial Specifications (based on vendor data):
| Parameter | Value | Source |
|---|---|---|
| Storage Buffer | Tris-based buffer, 50% glycerol, pH optimized for stability | |
| Storage Conditions | -20°C (long-term), 4°C (short-term) | |
| Purity | >90% (SDS-PAGE verified) |
While limited peer-reviewed studies exist, CLI_0469 is primarily used in:
Antigen Source: Serves as a recombinant antigen for generating polyclonal or monoclonal antibodies.
ELISA Kits: Commercially available as a coated antigen in immunoassays (e.g., CBM15’s ELISA kit).
Example Protocol:
Coat plates with CLI_0469 (50 µg/mL).
Block with casein buffer.
Incubate with primary antibodies (e.g., anti-C. botulinum sera).
Detect using HRP-conjugated secondary antibodies.
| Application | Purpose | Source |
|---|---|---|
| Serological Studies | Detecting anti-C. botulinum antibodies in sera | |
| Protein Interaction | Identifying binding partners via pull-down assays |
Functional Annotation: No published studies confirm its biological role in C. botulinum.
Toxicity Data: No safety assessments or bioactivity reports available.
Sequence Homology: Limited alignment with characterized proteins beyond UPF0059 family.
| Region | Residues | Function (Predicted) |
|---|---|---|
| N-Terminal | 1–50 (MEVQELFLLALAISLDAFGVILCIGINKGITLKSSIIFVFSFGFFQFFLSFLGGYIGTIF) | Membrane insertion signal? |
| C-Terminal | 134–183 (...SYINNLFYLFMSSLFMGLIATIICSLGIILSKYIKKISIISSYADYIGGIILILFGLKM LFF) | Cytosolic domain or binding site |
This protein likely functions as a manganese efflux pump.
KEGG: cbf:CLI_0469